menu
    • menu

    Company profile for Alligator Bioscience

    NEW Drugs in Dev: 6
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alligator develops antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. The company is active in the early stages of drug development, from idea to clinical phase II studies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alligator BioscienceSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Medicon Village, 223 81 Lund,
    Telephone
    Telephone
    + 46 (0)46 286 4280
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://alligatorbioscience.se/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Notice Of Annual General Meeting In Alligator Bioscience AB
    Notice Of Annual General Meeting In Alligator Bioscience AB

    30 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-30/notice-of-annual-general-meeting-in-alligator-bioscience-ab

    PHARMIWEB
    30 Mar 2026
    Share Share
    Alligator Bioscience Board Proposals For AGM Announced
    Alligator Bioscience Board Proposals For AGM Announced

    27 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-27/the-nomination-committees-proposals-regarding-the-board-of-directors-for-the-annual-general-meeting

    PHARMIWEB
    27 Mar 2026
    Share Share
    Alligator Bioscience Publishes Annual Report For 2025
    Alligator Bioscience Publishes Annual Report For 2025

    26 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-26/alligator-bioscience-publishes-annual-report-for-2025

    PHARMIWEB
    26 Mar 2026
    Share Share
    Alligator Bioscience's Mitazalimab Data To Debut At AACR 2026
    Alligator Bioscience's Mitazalimab Data To Debut At AACR 2026

    18 Mar 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/new-data-from-investigator%e2%80%91initiated-study-evaluating-alligator-biosciences-mitazalim-1148809

    ACCESSWIRE
    18 Mar 2026
    Share Share
    Alligator Bio Bolsters Ip Defense For Bispecific Antibody Tech
    Alligator Bio Bolsters Ip Defense For Bispecific Antibody Tech

    10 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-10/alligator-bioscience-strengthens-intellectual-property-protection-for-bispecific-antibody-platform

    PHARMIWEB
    10 Mar 2026
    Share Share
    Alligator Comments as Henlius Doses First in Ph2/3
    Alligator Comments as Henlius Doses First in Ph2/3

    02 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-02/alligator-bioscience-comments-on-henlius-dosing-first-patient-in-phase-23-breast-cancer-study-of-hl

    PHARMIWEB
    02 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search